e-learning
resources
Berlin 2008
Monday, 06.10.2008
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biological microchips in the early diagnosis of multidrug resistance in Kyrgiz Republic
J. Isakova, N. Sovhozova, M. Nurbaeva, M. Dushaliev, A. Usupopova, A. Aldashev (Bishkek, Kyrgyzstan)
Source:
Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session:
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Session type:
Thematic Poster Session
Number:
2533
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Isakova, N. Sovhozova, M. Nurbaeva, M. Dushaliev, A. Usupopova, A. Aldashev (Bishkek, Kyrgyzstan). Biological microchips in the early diagnosis of multidrug resistance in Kyrgiz Republic. Eur Respir J 2008; 32: Suppl. 52, 2533
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
Source: Eur Respir J 2014; 43: 1132-1141
Year: 2014
Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Multidrug resistant pulmonary TB: Characteristics of drug resistance profiles of MBT in Ukraine
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Frequincy of resistence on anti TB drugs in Republic of Srpska
Source: Eur Respir J 2004; 24: Suppl. 48, 656s
Year: 2004
Drug resistance in Bulgaria
Source: Eur Respir J 2001; 18: Suppl. 33, 471s
Year: 2001
Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Drug resistance in pulmonary tuberculosis in Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Anti-tuberculosis drug resistance in Sivas, Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Drug resistance to tuberculosis in Karachi
Source: Eur Respir J 2004; 24: Suppl. 48, 655s
Year: 2004
Treatment of multidrug resistant tuberculosis in penitentiary system of Tomsk Oblast
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Prevalence of drug resistance tuberculosis in the Republic of Moldova during the 1995-2005
Source: Eur Respir J 2007; 30: Suppl. 51, 700s
Year: 2007
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
Source: Eur Respir J 2012; 40: 133-142
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept